Selective or nonselective endothelin antagonists in porcine hypoxic pulmonary hypertension?

被引:20
|
作者
Franco-Cereceda, A [1 ]
Holm, P [1 ]
机构
[1] Karolinska Hosp, Dept Thorac Surg, S-17176 Stockholm, Sweden
关键词
endothelin; hypoxia; pig; pulmonary circulation;
D O I
10.1097/00005344-199800001-00128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We evaluated the hemodynamic effects of various endothelin (ET) receptor antagonists using selective and nonselective ETA and ETB receptor blockade in hypoxic pigs in vivo. BMS-182874 (10 mg/kg i.v.) TBC-1125lz (10 mg/kg i.v.), selective ETA receptor antagonists, attenuated hypoxia (Fi02 0.1)-evoked increase in pulmonary arterial pressure and pulmonary vascular resistance. Bosentan (10 mg/kg Lv.) a nonselective ETA and ETB receptor antagonist, cause essentially similar effects as ETA antagonism alone. No effects were observed after selective ETB blockade using BQ-788 (total dose 1 mg i.v.). The vasoconstrictor effect of exogenous ET was most effectively antagonized by TBC-11251z, followed by BMS-182874 and bosentan. The pulmonary vasodilator effect exerted by exogenous ET during hypoxia was reversed by BQ-788 and bosentan but not by TBC-11251z or BMS-182874. We can therefore conclude that ET contributes to hypoxic pulmonary vasoconstriction primarily through ETA receptor activation.
引用
收藏
页码:S447 / S452
页数:6
相关论文
共 50 条
  • [31] Hypoxic constriction of porcine distal pulmonary arteries: endothelium and endothelin dependence
    Liu, Q
    Sham, JSK
    Shimoda, LA
    Sylvester, JT
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 280 (05) : L856 - L865
  • [32] Endothelin-receptor antagonists in therapy of pulmonary arterial hypertension
    Ghofrani, H. A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 : S177 - S178
  • [33] Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension
    Montani, D.
    Humbert, M.
    REVUE DES MALADIES RESPIRATOIRES, 2010, 27 (02) : 103 - 105
  • [34] Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008
    Cacoub, P.
    Amoura, Z.
    Langleben, D.
    REVUE DE MEDECINE INTERNE, 2008, 29 (04): : 283 - 289
  • [35] Role of Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension
    Abman, Steven H.
    ANNUAL REVIEW OF MEDICINE, 2009, 60 : 13 - 23
  • [36] BENEFICIAL EFFECTS OF ENDOTHELIN RECEPTOR ANTAGONISTS ON SECONDARY PULMONARY HYPERTENSION
    Michalopoulou, H.
    Michaloliakou, M.
    Vaitsis, J.
    Stamatis, D.
    Stamatis, P.
    JOURNAL OF HYPERTENSION, 2009, 27 : S206 - S206
  • [37] Long-term effects of selective and nonselective endothelin receptor antagonists in mice with heart failure
    Cavasin, MA
    Carretero, OA
    Yang, F
    Oja-Tebbe, N
    Peng, HM
    Yang, XP
    JOURNAL OF CARDIAC FAILURE, 2002, 8 (04) : 254 - 261
  • [38] Endothelin causes portal and pulmonary hypertension in porcine endotoxemia.
    Yamamoto, S
    Burman, H
    ODonnell, CP
    Cahill, PA
    Robotham, JL
    FASEB JOURNAL, 1996, 10 (03): : 3454 - 3454
  • [39] Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock
    Yamamoto, S
    Burman, HP
    ODonnell, CP
    Cahill, PA
    Robotham, JL
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (03): : H1239 - H1249
  • [40] Pharmacodynamics of PD 156707, a selective endothelin receptor-A (ET(A)) antagonist, in acute hypoxic pulmonary hypertension (PH).
    Keiser, JA
    Schroeder, RL
    Hallak, H
    Uprichard, ACG
    Doherty, AM
    Haleen, SJ
    FASEB JOURNAL, 1997, 11 (03): : 206 - 206